Cargando…
Prediction of repurposed drugs for treating lung injury in COVID-19
Coronavirus disease (COVID-19) is an infectious disease discovered in 2019 and currently in outbreak across the world. Lung injury with severe respiratory failure is the leading cause of death in COVID-19, brought by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2). However, there still...
Autores principales: | He, Bing, Garmire, Lana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cornell University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280878/ https://www.ncbi.nlm.nih.gov/pubmed/32550243 |
Ejemplares similares
-
Prediction of repurposed drugs for treating lung injury in COVID-19
por: He, Bing, et al.
Publicado: (2020) -
ASGARD: A Single-cell Guided Pipeline to Aid Repurposing of Drugs
por: He, Bing, et al.
Publicado: (2021) -
ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs
por: He, Bing, et al.
Publicado: (2023) -
Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022) -
Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021)